Xortx Therapeutics Inc (XRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 11-2006 | 11-2005 | 11-2004 | 11-2003 | 11-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 58,178 | 41,889 | -122,245 | -35,815 | 4,962 |
| Depreciation Amortization | 15,228 | 9,912 | 6,505 | 4,969 | 4,112 |
| Income taxes - deferred | 5,824 | 4,403 | -7,709 | -13,538 | -80 |
| Accounts receivable | -21,098 | -29,272 | -6,695 | -7,820 | -5,053 |
| Accounts payable and accrued liabilities | 4,302 | 25,668 | 4,251 | 3,866 | 7,563 |
| Other Working Capital | -32,196 | -22,158 | -16,679 | 558 | -276 |
| Other Operating Activity | 24,255 | 8,176 | 165,409 | 66,761 | -2,382 |
| Operating Cash Flow | $54,493 | $38,618 | $22,837 | $18,981 | $8,846 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -19,170 | -17,070 | -8,949 | -5,107 | -4,644 |
| Net Acquisitions | -12,252 | -34,845 | -7,418 | -175 | N/A |
| Purchase Sale Intangibles | -4,000 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -4,000 | 0 | 6,000 | 0 | 0 |
| Investing Cash Flow | $-35,422 | $-51,915 | $-10,367 | $-5,282 | $-4,644 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 19,000 | 737 |
| Debt Repayment | -7,000 | -11,133 | -4,133 | -12,480 | -384 |
| Common Stock Issued | 3,610 | 2,175 | 53,150 | 273 | 63 |
| Common Stock Repurchased | N/A | N/A | N/A | -18,939 | -2,036 |
| Financing Cash Flow | $-3,390 | $-8,958 | $49,017 | $-12,146 | $-1,620 |
| Beginning Cash Position | 41,240 | 63,495 | 2,008 | 455 | 695 |
| End Cash Position | 56,921 | 41,240 | 63,495 | 2,008 | 455 |
| Net Cash Flow | $15,681 | $-22,255 | $61,487 | $1,553 | $-240 |
| Free Cash Flow | |||||
| Operating Cash Flow | 54,493 | 38,618 | 22,837 | 18,981 | 8,846 |
| Capital Expenditure | -19,932 | -17,070 | -8,985 | -5,107 | -4,644 |
| Free Cash Flow | 34,561 | 21,548 | 13,852 | 13,874 | 4,202 |